Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+11.57%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$46.8B
AUM Growth
+$3.84B
(+8.9%)
Cap. Flow
-$76.9M
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
25.08%
Holding
2,760
New
235
Increased
970
Reduced
814
Closed
157
Top Buys
| 1 |
Vanguard Russell 2000 ETF
VTWO
|
+$68.9M |
| 2 |
Global X Copper Miners ETF NEW
COPX
|
+$60.2M |
| 3 |
Intuitive Surgical
ISRG
|
+$53M |
| 4 |
Nike
NKE
|
+$50.3M |
| 5 |
Pan American Silver
PAAS
|
+$45.8M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$102M |
| 2 |
Invesco NASDAQ 100 ETF
QQQM
|
+$82.7M |
| 3 |
Apple
AAPL
|
+$81.2M |
| 4 |
DCP
DCP Midstream, LP
DCP
|
+$80.1M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$66.4M |
Sector Composition
| 1 | Technology | 30.24% |
| 2 | Industrials | 11.69% |
| 3 | Consumer Discretionary | 9.27% |
| 4 | Energy | 7.87% |
| 5 | Communication Services | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
On Holding
ONON
$14B
| $549K | ﹤0.01% |
16,631
-10,444
| -39% | -$345K |
|
1902
Liberty Latin America Class C
LILAK
$1.54B
| $548K | ﹤0.01% |
63,564
| – | – |
|
1903
Avidity Biosciences
RNA
$5.97B
| $547K | ﹤0.01% |
49,367
+6,904
| +16% | +$76.6K |
|
1904
S&T Bancorp
STBA
$1.49B
| $546K | ﹤0.01% |
20,098
+2,999
| +18% | +$81.5K |
|
1905
Marten Transport
MRTN
$949M
| $546K | ﹤0.01% |
25,386
| – | – |
|
|
EVRI
1906
DELISTED
Everi Holdings
EVRI
| $545K | ﹤0.01% |
37,720
| – | – |
|
|
IBTX
1907
DELISTED
Independent Bank Group, Inc.
IBTX
| $545K | ﹤0.01% |
15,784
| – | – |
|
1908
Gerdau
GGB
$6.19B
| $543K | ﹤0.01% |
124,932
-5,530
| -4% | -$24.1K |
|
1909
iShares MSCI Emerging Markets ETF
EEM
$19.6B
| $542K | ﹤0.01% |
13,710
-155,640
| -92% | -$6.16M |
|
1910
Nuvalent
NUVL
$5.66B
| $542K | ﹤0.01% |
12,808
+66
| +0.5% | +$2.79K |
|
1911
Sturm, Ruger & Co
RGR
$587M
| $540K | ﹤0.01% |
+10,198
| New | +$540K |
|
1912
Buckle
BKE
$3.06B
| $540K | ﹤0.01% |
15,606
+2,271
| +17% | +$78.6K |
|
1913
CommScope
COMM
$3.59B
| $540K | ﹤0.01% |
95,899
| – | – |
|
1914
Astrana Health
ASTH
$1.34B
| $539K | ﹤0.01% |
17,051
| – | – |
|
1915
Crinetics Pharmaceuticals
CRNX
$3.3B
| $537K | ﹤0.01% |
29,854
-256
| -0.9% | -$4.61K |
|
1916
Arcturus Therapeutics
ARCT
$489M
| $536K | ﹤0.01% |
19,071
+2,813
| +17% | +$79K |
|
1917
GrafTech
EAF
$199M
| $535K | ﹤0.01% |
10,611
+191
| +2% | +$9.63K |
|
1918
La-Z-Boy
LZB
$1.43B
| $535K | ﹤0.01% |
18,671
| – | – |
|
1919
Heidrick & Struggles
HSII
$1.02B
| $535K | ﹤0.01% |
20,193
| – | – |
|
|
RDFN
1920
DELISTED
Redfin
RDFN
| $533K | ﹤0.01% |
42,897
| – | – |
|
|
SAFE
1921
Safehold
SAFE
$1.15B
| $533K | ﹤0.01% |
22,442
+5,246
| +31% | +$124K |
|
1922
Nextracker
NXT
$10B
| $531K | ﹤0.01% |
13,346
| – | – |
|
1923
Clean Energy Fuels
CLNE
$561M
| $531K | ﹤0.01% |
107,093
+3,281
| +3% | +$16.3K |
|
1924
Treace Medical Concepts
TMCI
$442M
| $530K | ﹤0.01% |
20,725
+4,448
| +27% | +$114K |
|
|
CBAY
1925
DELISTED
Cymabay Therapeutics
CBAY
| $526K | ﹤0.01% |
+48,043
| New | +$526K |
|